Pure Global
NCT06053541

Morbid Rates After Spiriva Chronic Obstructive Pulmonary Disease (COPD) Protocol Change

Hospitalization, Mortality Rates and Costs Associated With Chronic Obstructive Pulmonary Disease (COPD) in Distrito Federal, Brazil, Before and After the Change in 2018 State COPD Protocol Version - Real-world Data
Boehringer Ingelheim·ClinicalTrials.govCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Pulmonary Disease, Chronic Obstructive
Study type
Observational
Sponsor & location
Primary sponsor
Boehringer Ingelheim
Location
São Paulo, Brazil
Timeline & enrollment
Phase
N/A
Start date
Apr 01, 2021
End date
Jul 01, 2021
Enrollment
1430 participants
Primary outcome

Occurrence of hospital admissions in Chronic Obstructive Pulmonary Disease (COPD) patients,Number of deaths of hospitalized Chronic Obstructive Pulmonary Disease (COPD) patients,Total costs associated with Chronic Obstructive Pulmonary Disease (COPD) hospitalizations,Infirmary beds

Summary

This study evaluates hospitalizations and mortality in patients with Chronic Obstructive
 Pulmonary Disease (COPD) before and after the implantation of a new COPD treatment plan
 (replacement of tiotropium soft mist inhaler for glycopyrronium dry powder inhaler) by the
 Health State Secretariat of Federal District in Brazil.

ICD-10 classifications
Chronic obstructive pulmonary disease, unspecifiedOther chronic obstructive pulmonary diseaseOther specified chronic obstructive pulmonary diseaseChronic obstructive pulmonary disease with acute exacerbation, unspecifiedChronic obstructive pulmonary disease with acute lower respiratory infection
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06053541
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06053541 through Pure Global AI's free database. This phase not specified trial is sponsored by Boehringer Ingelheim and is currently Completed. The study focuses on Pulmonary Disease, Chronic Obstructive. Target enrollment is 1430 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.